IPOs

BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings
Fierce Biotech
Wed, 01/22/25 - 07:28 pm
China
Takeda
Bristol Myers Squibb
IPOs
Ascentage Pharma
Sichuan Biokin Pharmaceutical
Shanghai Bao
Sionna, Odyssey join queue of biotechs testing investors’ IPO interest
BioPharma Dive
Tue, 01/21/25 - 11:16 am
IPOs
Sionna Therapeutics
cystic fibrosis
Odyssey Therapeutics
ulcerative colitis
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
Maze Therapeutics looks for IPO lodestar to guide kidney disease assets through clinical trials
Fierce Biotech
Tue, 01/7/25 - 07:04 pm
Maze Therapeutics
IPOs
kidney disease
Health In Tech IPO Fuels AI-Driven Health Coverage for Small Businesses
Xtalks
Sun, 01/5/25 - 09:33 pm
Health In Tech
IPOs
artificial intelligence
insurance
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Fierce Biotech
Fri, 01/3/25 - 11:17 am
IPOs
M&A
Anteris IPO Helps Bring Minimally Invasive Heart Valve Innovations
Xtalks
Fri, 01/3/25 - 10:52 am
Medtech
Anteris
IPOs
heart valve
Medline sets stage for blockbuster US IPO with confidential filing
MSN/Reuters
Thu, 12/19/24 - 10:10 am
Medline
IPOs
medical supplies
Medtech
Invizyne’s IPO Aims to Bring Sustainable Biomanufacturing
Xtalks
Fri, 12/6/24 - 09:36 am
IPOs
Invizyne
Biomanufacturing
What can we learn from 2024’s biotech IPOs?
Fierce Biotech
Fri, 12/6/24 - 09:25 am
biotech
IPOs
Jupiter Neurosciences Makes Way in CNS Treatments with $11M IPO
Xtalks
Wed, 12/4/24 - 11:09 pm
Jupiter Neurosciences
CNS
IPOs
Medical supplier Medline aims to raise over $5 billion in 2025 IPO, sources say
Yahoo/Reuters
Fri, 11/22/24 - 11:18 am
Medtech
Medline
medical supplies
IPOs
Nasdaq debutante Septerna swells its IPO to $331m
Pharmaphorum
Thu, 10/31/24 - 09:16 am
Septerna
IPOs
GPCR drugmaker Septerna amasses $288M in IPO
BioPharma Dive
Fri, 10/25/24 - 10:59 am
Septerna
IPOs
GPCRs
Septerna plans $158M IPO to fund clinical readouts for GPCR pipeline
Fierce Biotech
Mon, 10/21/24 - 09:42 am
Septerna
IPOs
GPCRs
Upstream swells IPO to $255M as it prepares to join Nasdaq along with CAMP4
Fierce Biotech
Fri, 10/11/24 - 09:32 am
Upstream Bio
IPOs
CAMP4 Therapeutics
NASDAQ
CAMP4 is latest biotech to eye IPO, while Upstream spells out $182M plans
Fierce Biotech
Mon, 10/7/24 - 09:58 pm
CAMP4 Therapeutics
IPOs
Upstream Bio
RNA
Septerna files for IPO on strength of preclinical data, vision for expanding GPCR landscape
Fierce Biotech
Thu, 10/3/24 - 10:32 am
Septerna
IPOs
hypoparathyroidism
Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy trials
Fierce Biotech
Wed, 10/2/24 - 10:40 am
Zephyrm Bioscience
Hong Kong
IPOs
cell therapy
graft vs host disease
Respiratory disorder biotech Upstream Bio files for a $100 million IPO
Renaissance Capital
Wed, 09/18/24 - 11:10 pm
Upstream Bio
monoclonal antibodies
IPOs
Respiratory

Pages